Avalo Therapeutics (AVTX) Return on Capital Employed Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,255.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 31,429.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2,503.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,400.00
10 Avalo Therapeutics 317.29 Mn 317.29 Mn - -4,570.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,570.00
Dec 31, 2025 -938.00
Sep 30, 2025 9,078.00
Jun 30, 2025 22,516.00
Mar 31, 2025 -7,207.00
Dec 31, 2024 7,508.00
Sep 30, 2024 -960.00
Jun 30, 2024 -789.00
Mar 31, 2024 25,543.00
Dec 31, 2023 15,820.00
Sep 30, 2023 14,910.00
Jun 30, 2023 -5,414.00
Mar 31, 2023 -8,343.00
Dec 31, 2022 -17,056.00
Sep 30, 2022 -15,402.00
Jun 30, 2022 -2,799.00
Mar 31, 2022 12,864.00
Dec 31, 2021 8,000.00
Sep 30, 2021 -201.00
Jun 30, 2021 -6,076.00
Mar 31, 2021 -9,318.00
Dec 31, 2020 -15,418.00
Sep 30, 2020 -10,156.00
Jun 30, 2020 -5,422.00
Mar 31, 2020 -8,921.00
Dec 31, 2019 3,604.00
Sep 30, 2019 6,642.00
Jun 30, 2019 -8,697.00
Mar 31, 2019 -11,308.00
Dec 31, 2018 -13,971.00
Sep 30, 2018 -23,024.00
Jun 30, 2018 37,842.00
Mar 31, 2018 70,671.00
Dec 31, 2017 53,490.00
Sep 30, 2017 60,026.00
Jun 30, 2017 -19,424.00
Mar 31, 2017 -57,344.00
Dec 31, 2016 -33,511.00